DBpedia 2014 |

DBpedia 2014

Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Biogen_Idec> ?p ?o. }

Showing items 1 to 100 of ±103 with 100 items per page.

Biogen_Idec abstract "Biogen Idec, Inc. is an American biotechnology company specializing in drugs for neurological disorders, autoimmune disorders and cancer. The company was formed in 2003 by the merger of Cambridge, Massachusetts-based Biogen Inc. and San Diego, California-based IDEC Pharmaceuticals (formed in 1986 by biotech pioneers Ivor Royston and Howard Birndorf). Biogen, one of the oldest biotechnology companies, was founded in 1978 in Geneva by several biologists, including Kenneth Murray of the University of Edinburgh, Phillip Sharp of the Massachusetts Institute of Technology, Walter Gilbert of Harvard (who served as CEO during the start-up phase) and Charles Weissmann, University of Zurich (who contributed the first product interferon-alpha).Biogen Idec stock is a component of several stock indices such as the S&P 500, S&P 1500, and NASDAQ-100.".
Biogen_Idec assets "9.049E9".
Biogen_Idec equity "6.426E9".
Biogen_Idec foundingYear "2003".
Biogen_Idec industry Biotechnology.
Biogen_Idec keyPerson Chairman.
Biogen_Idec keyPerson Chief_executive_officer.
Biogen_Idec location Massachusetts.
Biogen_Idec location United_States.
Biogen_Idec location Weston,_Massachusetts.
Biogen_Idec netIncome "1.266E9".
Biogen_Idec numberOfEmployees "4850".
Biogen_Idec operatingIncome "1.724E9".
Biogen_Idec product Interferon_beta_1a.
Biogen_Idec product Natalizumab.
Biogen_Idec product Rituximab.
Biogen_Idec revenue "5.048E9".
Biogen_Idec type Public_company.
Biogen_Idec wikiPageExternalLink 13209.html.
Biogen_Idec wikiPageExternalLink finance?source=ig&hl=en&q=biib&ie=UTF-8&oe=UTF-8&um=1&sa=N&tab=we&oi=property_suggestions&resnum=0&ct=property-revision&cd=1.
Biogen_Idec wikiPageExternalLink www.biogenidec.com.
Biogen_Idec wikiPageExternalLink www.biogenidec.com.
Biogen_Idec wikiPageExternalLink biogen_idec_foundation.aspx?ID=9515.
Biogen_Idec wikiPageExternalLink biogen-idec-axes-650-jobs-closes-san-diego-site-bets-future-on-neurology.
Biogen_Idec wikiPageID "380532".
Biogen_Idec wikiPageRevisionID "600525216".
Biogen_Idec assets "US$ 9.049 billion".
Biogen_Idec equity "US$ 6.426 billion".
Biogen_Idec foundation "2003".
Biogen_Idec hasPhotoCollection Biogen_Idec.
Biogen_Idec homepage www.biogenidec.com.
Biogen_Idec industry Biotechnology.
Biogen_Idec keyPeople "William D. Young George A. Scangos".
Biogen_Idec location Massachusetts.
Biogen_Idec location United_States.
Biogen_Idec location Weston,_Massachusetts.
Biogen_Idec logo File:Biogen_Idec_logo.png.
Biogen_Idec name "Biogen Idec, Inc.".
Biogen_Idec netIncome "US$ 1.266 billion".
Biogen_Idec numEmployees "4850".
Biogen_Idec operatingIncome "US$ 1.724 billion".
Biogen_Idec products Interferon_beta_1a.
Biogen_Idec products Natalizumab.
Biogen_Idec products Rituximab.
Biogen_Idec revenue "US$ 5.048 billion".
Biogen_Idec tradedAs NASDAQ-100.
Biogen_Idec tradedAs S&P_500.
Biogen_Idec type Public_company.
Biogen_Idec wordnet_type synset-company-noun-1.
Biogen_Idec subject Category:2003_establishments_in_Massachusetts.
Biogen_Idec subject Category:Biotechnology_companies_of_the_United_States.
Biogen_Idec subject Category:Companies_based_in_Cambridge,_Massachusetts.
Biogen_Idec subject Category:Companies_in_the_NASDAQ_Biotechnology_Index.
Biogen_Idec subject Category:Companies_listed_on_NASDAQ.
Biogen_Idec subject Category:National_Medal_of_Technology_recipients.
Biogen_Idec subject Category:Pharmaceutical_companies_established_in_2003.
Biogen_Idec subject Category:Pharmaceutical_companies_of_the_United_States.
Biogen_Idec point "42.366194444444446 -71.087".
Biogen_Idec type Abstraction100002137.
Biogen_Idec type BiotechnologyCompaniesOfTheUnitedStates.
Biogen_Idec type CompaniesBasedInCambridge,Massachusetts.
Biogen_Idec type CompaniesEstablishedIn2003.
Biogen_Idec type CompaniesInTheNASDAQBiotechnologyIndex.
Biogen_Idec type Company108058098.
Biogen_Idec type DrugCompany108002578.
Biogen_Idec type Group100031264.
Biogen_Idec type Institution108053576.
Biogen_Idec type Organization108008335.
Biogen_Idec type PharmaceuticalCompaniesOfTheUnitedStates.
Biogen_Idec type SocialGroup107950920.
Biogen_Idec type YagoLegalActor.
Biogen_Idec type YagoLegalActorGeo.
Biogen_Idec type YagoPermanentlyLocatedEntity.
Biogen_Idec type Agent.
Biogen_Idec type Company.
Biogen_Idec type Organisation.
Biogen_Idec type Organization.
Biogen_Idec type Business.
Biogen_Idec type Organization.
Biogen_Idec type Agent.
Biogen_Idec type SocialPerson.
Biogen_Idec type Thing.
Biogen_Idec type SpatialThing.
Biogen_Idec comment "Biogen Idec, Inc. is an American biotechnology company specializing in drugs for neurological disorders, autoimmune disorders and cancer. The company was formed in 2003 by the merger of Cambridge, Massachusetts-based Biogen Inc. and San Diego, California-based IDEC Pharmaceuticals (formed in 1986 by biotech pioneers Ivor Royston and Howard Birndorf).".
Biogen_Idec label "Biogen Idec".
Biogen_Idec label "Biogen Idec".
Biogen_Idec label "Biogen Idec".
Biogen_Idec label "Biogen Idec".
Biogen_Idec label "Biogen Idec".
Biogen_Idec label "بيوجن آيدك".
Biogen_Idec sameAs Biogen_Idec.
Biogen_Idec sameAs Biogen_Idec.
Biogen_Idec sameAs Biogen_Idec.
Biogen_Idec sameAs m.021jg2.
Biogen_Idec sameAs Q864338.
Biogen_Idec sameAs Q864338.
Biogen_Idec sameAs Biogen_Idec.
Biogen_Idec lat "42.366194444444446".
Biogen_Idec long "-71.087".
Biogen_Idec wasDerivedFrom Biogen_Idec?oldid=600525216.